Twice-Daily Trizivir versus Combivir-Abacavir in Antiretroviral-Experienced Adults with Human Immunodeficiency Virus-1 Infection: A Formulation-Switch Trial

Margaret A. Fischl, Alfred F. Burnside, Charles F. Farthing, Melanie A. Thompson, Nicholaos C. Bellos, Vanessa C. Williams, Teresa L. Kauf, Paul G. Wannamaker, Mark S. Shaefer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Twice-Daily Trizivir versus Combivir-Abacavir in Antiretroviral-Experienced Adults with Human Immunodeficiency Virus-1 Infection: A Formulation-Switch Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences